Breast cancer remains the most commonly diagnosed cancer among women worldwide, but it is not a single disease. Distinct molecular subtypes—defined by hormone receptor (HR) status, HER2 expression, and emerging genomic alterations such as ESR1…
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
